5Zacher L 见:Gate RH 主编 汪明明 崔速南 译.社区获得性肺炎:头号公敌[A].见:Gate RH,主编,汪明明,崔速南,译.美国最新临床医学问答感染性疾病[C].北京:海洋出版社,2000.431-439.
6Finch RG, Woodhead MA. Practical considerations and guidelines for the management of community-acquired pneumonia. Drugs, 1998,55:31-45.
7Battleman DS,Callahan M,Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia:link between quality of care and resource utilization. Arch Intern Med ,2002,162:682-688.
8Dudas V, Hopefl A, Jacobs R, et al. Anti-microbial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother,2001,34:446-452.
9Meehan TP, Fine M J, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA, 1997,278 :2080-2084.
10Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trim of a critical pathway for treatment of community-acquired pneumonia. Capital Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA,2000,283:749-755.
二级参考文献6
1Zacher L Gates RH 等.社区获得性肺炎.美国最新临床医学问答-感染性疾病[M].北京:海洋出版社,2000.431-439.
2Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med,1997,336:243-250.
3Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy.American Thoracic Society. Medical Section of the American Lurg Association. Am Rev Respir Dis, 1993,148:1418-1426.
4Fine MJ. Risk stratification for patients with community-acquired pneumonia. Int J Clin Pract Suppl, 2000,115:14-17.
